- Home
- CVR vs IMNN Comparison
CVR vs IMNN Comparison
Compare CVR & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- IMNN
- Stock Information
- Founded
- CVR 1920
- IMNN 1982
- Country
- CVR United States
- IMNN United States
- Employees
- CVR N/A
- IMNN N/A
- Industry
- CVR Industrial Machinery/Components
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- CVR Industrials
- IMNN Health Care
- Exchange
- CVR Nasdaq
- IMNN Nasdaq
- Market Cap
- CVR 11.1M
- IMNN 12.1M
- IPO Year
- CVR N/A
- IMNN 1985
- Fundamental
- Price
- CVR $12.00
- IMNN $0.96
- Analyst Decision
- CVR
- IMNN Buy
- Analyst Count
- CVR 0
- IMNN 2
- Target Price
- CVR N/A
- IMNN $14.00
- AVG Volume (30 Days)
- CVR 2.5K
- IMNN 32.7M
- Earning Date
- CVR 08-12-2025
- IMNN 08-13-2025
- Dividend Yield
- CVR 1.04%
- IMNN N/A
- EPS Growth
- CVR N/A
- IMNN N/A
- EPS
- CVR N/A
- IMNN N/A
- Revenue
- CVR $26,379,081.00
- IMNN N/A
- Revenue This Year
- CVR N/A
- IMNN N/A
- Revenue Next Year
- CVR N/A
- IMNN N/A
- P/E Ratio
- CVR N/A
- IMNN N/A
- Revenue Growth
- CVR N/A
- IMNN N/A
- 52 Week Low
- CVR $8.15
- IMNN $0.37
- 52 Week High
- CVR $22.27
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- CVR 38.45
- IMNN 43.51
- Support Level
- CVR $13.20
- IMNN $0.93
- Resistance Level
- CVR $13.86
- IMNN $1.03
- Average True Range (ATR)
- CVR 0.79
- IMNN 0.26
- MACD
- CVR -0.26
- IMNN -0.10
- Stochastic Oscillator
- CVR 0.00
- IMNN 2.71
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).